Fundraising Fox
🦊/Companies
Sign in

Asalyxa Bio

2 known investors

Find your way into Asalyxa Bio

Developing an immune cell targeting platform to create first-in-class particle drug products for high unmet medical needs.

Investors · 2

WMU Biosciences Research & Commercialization Centerlisted by WMU Biosciences Research & Commercialization CenterKalamazoo · $100K – $250K

How we know: WMU Biosciences Research & Commercialization Center's portfolio page · Not right? Tell us

Funding

SEC filings, press & company announcements

$2M disclosed across 1 of 2 rounds · 2021

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Ann Arbor's Asalyxa Bio Raises $2 Million To Start Clinical Trials for Neutrophil-Targeting Drug Delivery Techcronicle.press · Mar 2021UM spinout drug company Asalyxa Bio hauls in $2 million seed funding round | Crain's Detroit Businesscrainsdetroit.com · Feb 2021Asalyxa Bio Closes Seed Financing to Advance Lead Program into First-in-Human Clinical Studiesprnewswire.com · Feb 2021Asalyxa Bio Closes Over $2M Seed Financing - FinSMEsfinsmes.com · Feb 2021Asalyxa Bio Updateorangegrovebio.com · Feb 2021U-M spinout Asalyxa Bio developing inflammatory treatment platform, aiding COVID-19 patients | University of Michigan Newsnews.umich.edu · Aug 2020

Frequently asked questions

What does Asalyxa Bio do?
Developing an immune cell targeting platform to create first-in-class particle drug products for high unmet medical needs.
Who are Asalyxa Bio's investors?
Asalyxa Bio's investors include LoftyInc Capital, WMU Biosciences Research & Commercialization Center.
How much funding has Asalyxa Bio raised?
Asalyxa Bio has disclosed $2M raised across 1 of its 2 known rounds.